KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Finished Goods (2016 - 2025)

Historic Finished Goods for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Boston Scientific's Finished Goods rose 283.65% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 283.65%. This contributed to the annual value of $1.8 billion for FY2025, which is 283.65% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Finished Goods is $1.8 billion, which was up 283.65% from $1.8 billion recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Finished Goods peaked at $1.8 billion during Q4 2025, and registered a low of $921.0 million during Q1 2021.
  • Over the past 5 years, Boston Scientific's median Finished Goods value was $1.4 billion (recorded in 2023), while the average stood at $1.4 billion.
  • In the last 5 years, Boston Scientific's Finished Goods crashed by 706.36% in 2021 and then skyrocketed by 3243.0% in 2023.
  • Boston Scientific's Finished Goods (Quarter) stood at $1.0 billion in 2021, then increased by 13.8% to $1.2 billion in 2022, then soared by 31.26% to $1.5 billion in 2023, then grew by 16.98% to $1.8 billion in 2024, then rose by 2.84% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q4 2025, $1.8 billion for Q3 2025, and $1.8 billion during Q2 2025.